Original language | English |
---|---|
Pages (from-to) | 569-574 |
Number of pages | 6 |
Journal | Oncology Research - Anticancer drug design |
Volume | 16 |
Publication status | Published - 2008 |
Metabolites of the radiosensitizer nicotinamide are unlikely to contribute to the degree of emesis observed with the parent drug.
David Hirst
Research output: Contribution to journal › Article › peer-review